Bernard J. Jasmin

University of Ottawa — Canada

Biochemistry, Genetics and Molecular Biology · Life Sciences

47h-index6.0kcitations168works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Muscle Physiology and Disorders(90), Cholinesterase and Neurodegenerative Diseases(27), Nerve injury and regeneration(24), Genetic Neurodegenerative Diseases(23), Adipose Tissue and Metabolism(21)

Publications168 total

Disruptions of Cell Signaling Pathways in Myotonic Dystrophy Type 1 (DM1) Skeletal Muscle, their Pathogenic Impact and Potential for Combinatorial Therapeutics
Journal of Biological Chemistry·2026Open Access
Dystrophic Skeletal Muscle Phenotypes Can Be Horizontally Transferred via Fecal Microbiome Transplantations
The FASEB Journal·2025Open Access
Report on the 6th Ottawa International Conference on Neuromuscular Disease & Biology – September 7–9, 2023, Ottawa, Canada
Journal of Neuromuscular Diseases·2025Open Access
The <scp>AMPK</scp> allosteric activator <scp>MK</scp> ‐8722 improves the histology and spliceopathy in myotonic dystrophy type 1 ( <scp>DM1</scp> ) skeletal muscle
The FASEB Journal·2024· 4 citedOpen Access
Changes in Physiopathological Markers in Myotonic Dystrophy Type 1 Skeletal Muscle: A 3-Year Follow-up Study
Journal of Neuromuscular Diseases·2024· 2 citedOpen Access
Pannexin 1 dysregulation in Duchenne muscular dystrophy and its exacerbation of dystrophic features in mdx mice
Skeletal Muscle·2024· 3 citedOpen Access
Revitalising medical governance for a healthier world: the urgent case for a director of planetary health in every faculty of medicine
The Lancet Planetary Health·2024· 4 citedOpen Access
Vorinostat Improves Myotonic Dystrophy Type 1 Splicing Abnormalities in DM1 Muscle Cell Lines and Skeletal Muscle from a DM1 Mouse Model
International Journal of Molecular Sciences·2023· 9 citedOpen Access
Pharmacological inhibition of HDAC6 improves muscle phenotypes in dystrophin-deficient mice by downregulating TGF-β via Smad3 acetylation
Nature Communications·2022· 40 citedOpen Access
Identifying FDA-Approved Drugs that Upregulate Utrophin A as a Therapeutic Strategy for Duchenne Muscular Dystrophy
Methods in molecular biology·2022· 2 cited
Clinical improvement of DM1 patients reflected by reversal of disease-induced gene expression in blood
BMC Medicine·2022· 5 citedOpen Access
Combinatorial treatment with exercise and AICAR potentiates the rescue of myotonic dystrophy type 1 mouse muscles in a sex-specific manner
Human Molecular Genetics·2022· 17 cited
Sex‐dependent role of Pannexin 1 in regulating skeletal muscle and satellite cell function
Journal of Cellular Physiology·2022· 6 cited
Pharmacological and exercise‐induced activation of AMPK as emerging therapies for myotonic dystrophy type 1 patients
The Journal of Physiology·2022· 16 cited
Severe Muscle Deconditioning Triggers Early Extracellular Matrix Remodeling and Resident Stem Cell Differentiation into Adipocytes in Healthy Men
International Journal of Molecular Sciences·2022· 16 citedOpen Access
Combinatorial therapies for rescuing myotonic dystrophy type 1 skeletal muscle defects
Trends in Molecular Medicine·2022· 6 cited
LRRK2 Phosphorylates Neuronal Elav RNA-Binding Proteins to Regulate Phenotypes Relevant to Parkinson’s Disease
2022· 3 citedOpen Access
Pharmacological inhibition of HDAC6 downregulates TGF-β via Smad2/3 acetylation and improves dystrophin-deficient muscles
2022· 3 citedOpen Access
A novel CARM1–HuR axis involved in muscle differentiation and plasticity misregulated in spinal muscular atrophy
Human Molecular Genetics·2021· 5 cited
The multifunctional RNA-binding protein Staufen1: an emerging regulator of oncogenesis through its various roles in key cellular events
Cellular and Molecular Life Sciences·2021· 30 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Joe V. Chakkalakal(9), Guy Bélanger(8), Robin N. Michel(6), Vladimir Ljubicic(6), Eva R. Chin(5), Jean Cartaud(5), Lindsay Angus(5), Julie Deschênes‐Furry(5), Anthony O. Gramolini(5), Laurent Schaeffer(4), Pedro Miura(4), Nora I. Perrone‐Bizzozero(4), John A. Lunde(4), Jean‐Pierre Changeux(3), Lynn A. Megeney(3), Jennifer Thompson(3), Robin J. Parks(3), Jonathon M. Tinsley(3), Kay E. Davies(3), Aymeric Ravel‐Chapuis(3)